Long-term response to pimitespib in postoperative recurrent gastrointestinal stromal tumors with PDGFRA D842V mutation: a case report
Abstract Background Exon 18 D842V, which is a point mutation from aspartic acid to valine at codon 842, is the most frequent mutation in Platelet-Derived Growth Factor Receptor alpha (PDGFRA)-mutated gastrointestinal stromal tumor (GIST). In the Japanese GIST guidelines, no standard systematic thera...
Main Authors: | Ryugo Teranishi, Tsuyoshi Takahashi, Yukinori Kurokawa, Takuro Saito, Kazuyoshi Yamamoto, Kotaro Yamashita, Koji Tanaka, Tomoki Makino, Kiyokazu Nakajima, Hidetoshi Eguchi, Yuichiro Doki |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-04-01
|
Series: | Surgical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40792-023-01637-4 |
Similar Items
-
The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
by: Alessandro Rizzo, et al.
Published: (2021-02-01) -
Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor
by: Sebastian Bauer, et al.
Published: (2021-07-01) -
An overview of agents and treatments for PDGFRA-mutated gastrointestinal stromal tumors
by: Yingchao Sun, et al.
Published: (2022-08-01) -
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs
by: Gloria Ravegnini, et al.
Published: (2022-10-01) -
ALK expressed in a gastrointestinal stromal tumor harboring PDGFRA p. D842V mutation:a case report
by: Jun Fan, et al.
Published: (2020-01-01)